Which Medications Can Cause Gum Overgrowth?

Gum tissue that gradually becomes thicker, firmer and more prominent is easy to misread. Many people assume they have simply not been cleaning well enough, and respond by brushing harder — which does not resolve the underlying cause and can irritate the tissue further.

For a proportion of patients, the explanation lies outside the mouth entirely. Certain prescribed medicines are recognised as causing the gum tissue to enlarge, a condition known clinically as drug-induced gingival enlargement or drug-induced gingival overgrowth. It is a well-documented effect, affecting a minority of people who take the medicines concerned.

This article explains which medicine groups are associated with the condition, why the effect occurs, how it is distinguished from other causes of swollen gums, and — crucially — why the management route runs through both your dental team and the clinician who prescribed the medicine.

This article is educational and does not advise anyone to stop, reduce or change a prescribed medicine. Only the prescribing clinician can make that decision.

At a Glance

Three medicine groups are most commonly associated with gum overgrowth: certain calcium channel blockers used for blood pressure and angina, the anticonvulsant phenytoin, and the immunosuppressant ciclosporin used after organ transplantation. The enlargement typically begins at the small triangles of gum between the teeth and is substantially worsened by plaque, which is why meticulous cleaning and professional hygiene support form the foundation of management.

The Three Main Medicine Groups Involved

Calcium Channel Blockers

This is the group most frequently encountered in general dental practice, simply because these medicines are widely prescribed for high blood pressure and angina. Nifedipine has the strongest association, with amlodipine, felodipine, diltiazem and verapamil also implicated to varying degrees.

Only a minority of people taking these medicines develop noticeable gum enlargement. Reported frequencies vary considerably between studies, partly because the threshold for what counts as "overgrowth" differs and partly because plaque levels in the study populations differ.

Anticonvulsants

Phenytoin has the longest-established association of any medicine with this condition, described in the dental literature for decades. Sodium valproate and some other anticonvulsants have also been reported, though less consistently.

Immunosuppressants

Ciclosporin, used to prevent rejection after organ transplantation and in some autoimmune conditions, is the principal example. Patients taking ciclosporin alongside a calcium channel blocker — a combination that occurs in transplant care — may experience a more pronounced effect than either medicine produces alone.

Why Do These Medicines Affect Gum Tissue?

The mechanisms are not identical across the three groups, and the picture is still being refined by research. The common thread is an effect on fibroblasts — the cells in the gum's connective tissue responsible for producing and turning over collagen.

In simplified terms, these medicines appear to shift the balance between how much collagen the tissue produces and how much it breaks down. When production outpaces breakdown, connective tissue accumulates and the gum becomes bulkier. Calcium channel blockers and ciclosporin also influence calcium movement and immune signalling within these cells, which is thought to contribute.

Two points follow from this that matter clinically. First, the overgrowth is predominantly an increase in fibrous connective tissue rather than fluid swelling, which is why it feels firm rather than soft. Second, the effect is strongly amplified by inflammation — which is where plaque enters the picture.

The Role of Plaque: Why Cleaning Matters So Much

Drug-induced gum overgrowth is not caused by plaque, but it is consistently made worse by it. Plaque-driven inflammation appears to act as a trigger that allows the medicine's effect on the tissue to express itself more fully.

This has an encouraging practical implication. Even where the medicine cannot be changed, improving plaque control at the gum margin can reduce the severity of the enlargement and slow its progression. In some patients this alone produces a noticeable improvement.

It also has an awkward implication: the overgrowth itself makes cleaning harder. Enlarged tissue creates deeper crevices and false pockets that trap plaque, which increases inflammation, which worsens the overgrowth. Breaking that cycle usually requires professional support rather than home effort alone. Professional hygiene care is generally the starting point, often with more frequent appointments than standard.

How It Is Recognised

Drug-induced gum overgrowth has a reasonably characteristic presentation:

• It usually starts at the interdental papillae — the small triangles of gum between the teeth — before extending across the tooth surfaces
• It is typically most obvious at the front of the mouth, and more so on the outer surfaces
• The tissue feels firm and fibrous rather than soft and boggy
• It is generally not painful, which is one reason it can progress before being noticed
• Onset is usually within the first few months of starting the medicine, though it can be slower
• It affects areas with teeth; regions without teeth are typically spared

None of these features is diagnostic on its own. Swollen or enlarged gum tissue has several possible causes, including plaque-related gum disease, hormonal changes during pregnancy, certain blood disorders, and less common conditions. Distinguishing between them requires clinical examination, a full medicine history, and sometimes further investigation. This is not something to diagnose from a description or a photograph.

How It Is Managed

Management is normally staged, and involves coordination between your dental team and your prescriber.

Step One: Stabilise the Inflammation

Thorough professional cleaning, combined with a reviewed and reinforced home routine, is almost always the first step. This addresses the amplifying factor even when the underlying cause remains. Your dental team may recommend specific interdental cleaning aids suited to the shape of the enlarged tissue.

Step Two: Review the Medicine — With the Prescriber

Where the enlargement is significant and persists despite good plaque control, your dentist may write to your GP or specialist to ask whether an alternative medicine within the same therapeutic class could be considered.

This is a request for a medical review, not a dental decision. The prescriber weighs the dental issue against the reason the medicine was prescribed in the first place — and for many patients, particularly transplant recipients and people with epilepsy, continuing effective treatment takes clear precedence. Under no circumstances should the medicine be stopped or reduced without that conversation.

Step Three: Consider Surgical Reduction Where Appropriate

If enlarged tissue persists after the above, reshaping or removing excess tissue may be discussed. Our page on gum contouring explains what such procedures involve.

An important caveat applies here: if the causative medicine continues and plaque control is not maintained, tissue can re-enlarge over time. This does not make the procedure inappropriate, but it does shape expectations and means long-term maintenance becomes part of the plan rather than an optional extra. Our related article on whether laser gum contouring is permanent explores this in more depth.

What to Do If You Recognise This Pattern

If you take one of the medicines described and have noticed your gums becoming bulkier:

1. Continue taking your medicine as prescribed. Stopping it independently may carry serious risks depending on why it was prescribed.
2. Arrange a dental assessment and bring a full, current list of your medicines including doses.
3. Mention when the change started and whether it coincided with starting or changing a medicine.
4. Expect a plaque-control phase first, and engage with it — it materially affects the outcome.
5. Allow your dental team to contact your prescriber if they consider a medical review appropriate.

A dental examination is where this assessment begins, including recording the extent of the enlargement so change can be tracked over time.

Key Points to Remember

• Three medicine groups are principally implicated: certain calcium channel blockers, phenytoin, and ciclosporin
• Only a minority of people taking them are affected, and severity varies considerably
• Plaque does not cause the condition but substantially worsens it, making cleaning the most powerful thing within a patient's control
• The enlargement is fibrous and usually painless, which is why it can progress unnoticed
• Never stop or alter a prescribed medicine because of gum changes — the route is a dental assessment followed, if appropriate, by a prescriber review
• Surgical reduction is possible but not a standalone answer if the medicine continues and plaque control lapses
• Several other conditions cause gum enlargement, so clinical examination is necessary rather than optional

Frequently Asked Questions

Conclusion

Gum tissue that thickens over time is not always a reflection of cleaning habits. For patients taking certain calcium channel blockers, phenytoin or ciclosporin, the medicine itself may be driving a change in the connective tissue of the gum — a recognised effect that is amplified, though not caused, by plaque.

The practical response is clear-cut. Keep taking the medicine, arrange a dental assessment with a full list of what you take, and engage seriously with the plaque-control phase, because it is the element most within your influence and it genuinely affects severity. Where the enlargement persists, your dental team can request a medical review, and reshaping procedures may be discussed — with realistic expectations about maintenance.

What should not happen is self-diagnosis, self-directed changes to medication, or brushing harder in the belief that the tissue is simply dirty.

Dental symptoms and treatment options should always be assessed individually during a clinical examination.